Pharmacovigilance: Follow the Evidence

Co-Moderator(s)

• 

  Nelson Pace, PhD, SM

  Director of Epidemiology
  AbbVie, Inc.
  North Chicago, United States
• 

  Caitlin Knox, PhD MPH (she/her/hers)

  Sr Dir, Pharmacoepidemiology
  Regeneron Pharmaceuticals, Inc., United States

Presentations:

• 8:30 AM – 8:45 AM ADT

  On the use of different reference sets in data mining spontaneous reports for pharmacovigilance
  

  Presenting Author: Christopher Gravel, PhD (he/him/his) – School of Epidemiology and Public Health, University of Ottawa
• 8:45 AM – 9:00 AM ADT

  Statistical Outlier Detection to Identify Uncoded High-Dose Case Reports in VigiBase for Medication Error Signals
  

  Presenting Author: Eva-Lisa Meldau, MSc – Uppsala Monitoring Centre
• 9:00 AM – 9:15 AM ADT

  Development and evaluation of phenotype algorithms for the European Medicines Agency designated medical events in a network of real-world data
  

  Presenting Author: Azza Shoaibi, PhD, MPH – Janssen Research & Development
• 9:15 AM – 9:30 AM ADT

  Application of new signal detection methods to EUROmediCAT data: Bayesian Confidence Propagation Neural Network-Biclustering (BCPNN-Bic) and BCPNN-Bicluster-Bayesian Hierarchical Modelling (BBBHM)
  

  Presenting Author: Hannah Johnson, MSc (she/her/hers) – St George's, University of London
• 9:30 AM – 9:45 AM ADT

  Signal detection using longitudinal healthcare claims data; a pilot study using Lantus as case drug
  

  Presenting Author: Lockwood Taylor, PhD – IQVIA
• 9:45 AM – 10:00 AM ADT

  Investigating Potential Differences in the Safety Profiles of Biosimilars relative to Originator Products using a Tree-Based Scan Statistic
  

  Presenting Author: José J. Hernández-Muñoz, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration